Cargando…
Use of immunohistochemical biomarkers as independent predictor of neoplastic progression in Barrett's oesophagus surveillance: A systematic review and meta-analysis
INTRODUCTION: The low incidence of oesophageal adenocarcinoma (EAC) in Barrett's oesophagus (BE) patients reinforces the need for risk stratification tools to make BE surveillance more effective. Therefore, we have undertaken a systematic review and meta-analysis of published studies on immunoh...
Autores principales: | Janmaat, Vincent T., van Olphen, Sophie H., Biermann, Katharina E., Looijenga, Leendert H. J., Bruno, Marco B., Spaander, Manon C. W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5653304/ https://www.ncbi.nlm.nih.gov/pubmed/29059206 http://dx.doi.org/10.1371/journal.pone.0186305 |
Ejemplares similares
-
Value of cyclin A immunohistochemistry for cancer risk stratification in Barrett esophagus surveillance: A multicenter case–control study
por: van Olphen, Sophie H., et al.
Publicado: (2016) -
RADIOFREQUENCY ABLATION AND ENDOSCOPIC MUCOSAL IN TREATMENT OF EARLY NEOPLASTIC BARRETT’S OESOPHAGUS
por: Callaghan, B, et al.
Publicado: (2018) -
A personalized and dynamic risk estimation model: The new paradigm in Barrett’s esophagus surveillance
por: Roumans, Carlijn A. M., et al.
Publicado: (2022) -
Update on endoscopic treatment of Barrett’s oesophagus and Barrett’s oesophagus–related neoplasia
por: Pech, Oliver, et al.
Publicado: (2020) -
Barrett's oesophagus and adenocarcinoma
por: Caygill, Christine PJ, et al.
Publicado: (2004)